In one study of 250 prostate cancer patients with biochemical recurrence, 18F-Choline PET/CT showed 77% sensitivity for cancer detection at a PSA level greater than 0.3 ng/mL and had a particularly high sensitivity in patients treated with ADT as compared to those who did not receive ADT [40]. The gene discussed is KLK3; the disease is cancer.